Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
2015-01-01 Peyrin-Biroulet, L; Sandborn, W; Sands, Be; Reinisch, W; Bemelman, W; Bryant, Rv; D'Haens, G; Dotan, I; Dubinsky, M; Feagan, B; Fiorino, G; Gearry, R; Krishnareddy, S; Lakatos, Pl; Loftus, Ev; Marteau, P; Munkholm, P; Murdoch, Tb; Ordas, I; Panaccione, R; Riddell, Rh; Ruel, J; Rubin, Dt; Samaan, M; Siegel, Ca; Silverberg, Ms; Stoker, J; Schreiber, S; Travis, S; Van Assche, G; Danese, S; Panes, J; Bouguen, G; O'Donnell, S; Pariente, B; Winer, S; Hanauer, S; Colombel, Jf
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients
2017-01-01 Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S
Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile
2019-01-01 Argollo, M; Kotze, Pg; Lamonaca, L; Gilardi, D; Furfaro, F; Yamamoto, T; Danese, S
Dose Optimization Is Effective in Patients With Ulcerative Colitis Losing Response to Infliximab: A Collaborative Multicentre Retrospective Study
2013-01-01 Cesarini, M; Katsanos, K; Ellul, P; Lakatos, Pl; Papamichael, K; Caprioli, F; Tsianos, Ev; Mantzaris, Gj; Danese, S; Fiorino, G
The nocebo effect: a clinical challenge in the era of biosimilars
2018-01-01 Pouillon, L; Socha, M; Demore, B; Thilly, N; Abitbol, V; Danese, S; Peyrin-Biroulet, L
Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball?
2015-01-01 Danese, S; Peyrin-Biroulet, L; Fiorino, G
Induction of Clinical and Endoscopic Remission of Mild to Moderately Active Ulcerative Colitis With Budesonide MMX (R) 9 mg: Analysis of Pooled Data from Two Phase 3 Studies
2011-01-01 Sandborn, W; Travis, S; Bala, N; Danese, S; Moro, L; Ballard, Ed; Gautille, T; Bagin, B; Huang, M
The CUE (Catholic University Epidemiological) study: Prevalence of H-pylori infection in a population working at a university hospital
1998-01-01 Gasbarrini, G; Gasbarrini, A; Anti, M; Armuzzi, A; Franceschi, F; Lippi, Me; Candelli, M; Paolucci, M; Cicconi, V; Danese, S; Canducci, F; Cammarota, G; Pretolani, S; Stroffolini, T
Biologic Therapies in Ulcerative Colitis: Primi Inter Pares?
2018-01-01 Allocca, M; Fiorino, G; Gilardi, D; Preatoni, P; Papa, A; Peyrin-Biroulet, L; Danese, S
Medico-surgical Management: A Solid Therapeutic Pillar for Improved Patients' Outcomes in Inflammatory Bowel Diseases
2019-01-01 Kotze, Pg; Peyrin-Biroulet, L; Danese, S
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration
2018-01-01 Danese, S; Furfaro, F; Vetrano, S
MRI in Crohn's disease : current and future clinical applications
2012-01-01 Fiorino, G.; Bonifacio, C.; Malesci, A.; Balzarini, L.; Danese, S.
Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis
2019-01-01 Pouillon, L; Rousseau, H; Busby-Venner, H; Bittencourt, Md; Choukour, M; Gauchotte, G; Zallot, C; Danese, S; Baumann, C; Peyrin-Biroulet, L
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12(low/neg) accessory cells with dendritic-cell features
2006-01-01 Rutella, S; Bonanno, G; Procoli, A; Mariott, A; De Ritis, Dg; Curti, A; Danese, S; Pessina, G; Pandolfi, S; Natoni, F; Di Febo, A; Scambia, G; Manfredini, R; Salati, S; Ferrari, S; Pierelli, L; Leone, G; Lemoli, Rm
Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach
2019-01-01 Peyrin-Biroulet, L; Danese, S; Cummings, F; Atreya, R; Greveson, K; Pieper, B; Kang, T
Management of gastrointestinal and liver diseases during pregnancy
2014-01-01 van der Woude, Cj; Metselaar, Hj; Danese, S
COMPARATIVE ACCURACY OF US VERSUS MRI AND COLONOSCOPY IN ASSESSING DISEASE ACTIVITY AND COMPLICATIONS AND INFLUENCING THE DECISION-MAKING PROCESS IN CROHN'S DISEASE
2017-01-01 Allocca, M; Fiorino, G; Bonifacio, C; Furfaro, F; Radice, S; Gilardi, D; Peyrin-Biroulet, L; Danese, S
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds
2010-01-01 Di Pucchio, T; Danese, S; De Cristofaro, R; Rutella, S
Comparison between intravenous iron gluconate alone and intravenous iron gluconate plus levofolinic acid for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease
2006-01-01 Papa, A; Danese, S; Guglielmo, S; Roberto, I; Covino, M; Grillo, A; Urgesi, R; Semeraro, S; Bonizzi, M; Tagliaferri, F; Guidi, L; de Vitis, I; Fedeli, G; Gasbarrini, G; Gasbarrini, A
Helicobacter pylori infection in rheumatoid arthritis - Reply
2001-01-01 Danese, S; Gasbarrini, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target | 1-gen-2015 | Peyrin-Biroulet, L; Sandborn, W; Sands, Be; Reinisch, W; Bemelman, W; Bryant, Rv; D'Haens, G; Dotan, I; Dubinsky, M; Feagan, B; Fiorino, G; Gearry, R; Krishnareddy, S; Lakatos, Pl; Loftus, Ev; Marteau, P; Munkholm, P; Murdoch, Tb; Ordas, I; Panaccione, R; Riddell, Rh; Ruel, J; Rubin, Dt; Samaan, M; Siegel, Ca; Silverberg, Ms; Stoker, J; Schreiber, S; Travis, S; Van Assche, G; Danese, S; Panes, J; Bouguen, G; O'Donnell, S; Pariente, B; Winer, S; Hanauer, S; Colombel, Jf | |
| Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients | 1-gen-2017 | Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S | |
| Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile | 1-gen-2019 | Argollo, M; Kotze, Pg; Lamonaca, L; Gilardi, D; Furfaro, F; Yamamoto, T; Danese, S | |
| Dose Optimization Is Effective in Patients With Ulcerative Colitis Losing Response to Infliximab: A Collaborative Multicentre Retrospective Study | 1-gen-2013 | Cesarini, M; Katsanos, K; Ellul, P; Lakatos, Pl; Papamichael, K; Caprioli, F; Tsianos, Ev; Mantzaris, Gj; Danese, S; Fiorino, G | |
| The nocebo effect: a clinical challenge in the era of biosimilars | 1-gen-2018 | Pouillon, L; Socha, M; Demore, B; Thilly, N; Abitbol, V; Danese, S; Peyrin-Biroulet, L | |
| Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball? | 1-gen-2015 | Danese, S; Peyrin-Biroulet, L; Fiorino, G | |
| Induction of Clinical and Endoscopic Remission of Mild to Moderately Active Ulcerative Colitis With Budesonide MMX (R) 9 mg: Analysis of Pooled Data from Two Phase 3 Studies | 1-gen-2011 | Sandborn, W; Travis, S; Bala, N; Danese, S; Moro, L; Ballard, Ed; Gautille, T; Bagin, B; Huang, M | |
| The CUE (Catholic University Epidemiological) study: Prevalence of H-pylori infection in a population working at a university hospital | 1-gen-1998 | Gasbarrini, G; Gasbarrini, A; Anti, M; Armuzzi, A; Franceschi, F; Lippi, Me; Candelli, M; Paolucci, M; Cicconi, V; Danese, S; Canducci, F; Cammarota, G; Pretolani, S; Stroffolini, T | |
| Biologic Therapies in Ulcerative Colitis: Primi Inter Pares? | 1-gen-2018 | Allocca, M; Fiorino, G; Gilardi, D; Preatoni, P; Papa, A; Peyrin-Biroulet, L; Danese, S | |
| Medico-surgical Management: A Solid Therapeutic Pillar for Improved Patients' Outcomes in Inflammatory Bowel Diseases | 1-gen-2019 | Kotze, Pg; Peyrin-Biroulet, L; Danese, S | |
| Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration | 1-gen-2018 | Danese, S; Furfaro, F; Vetrano, S | |
| MRI in Crohn's disease : current and future clinical applications | 1-gen-2012 | Fiorino, G.; Bonifacio, C.; Malesci, A.; Balzarini, L.; Danese, S. | |
| Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis | 1-gen-2019 | Pouillon, L; Rousseau, H; Busby-Venner, H; Bittencourt, Md; Choukour, M; Gauchotte, G; Zallot, C; Danese, S; Baumann, C; Peyrin-Biroulet, L | |
| Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12(low/neg) accessory cells with dendritic-cell features | 1-gen-2006 | Rutella, S; Bonanno, G; Procoli, A; Mariott, A; De Ritis, Dg; Curti, A; Danese, S; Pessina, G; Pandolfi, S; Natoni, F; Di Febo, A; Scambia, G; Manfredini, R; Salati, S; Ferrari, S; Pierelli, L; Leone, G; Lemoli, Rm | |
| Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach | 1-gen-2019 | Peyrin-Biroulet, L; Danese, S; Cummings, F; Atreya, R; Greveson, K; Pieper, B; Kang, T | |
| Management of gastrointestinal and liver diseases during pregnancy | 1-gen-2014 | van der Woude, Cj; Metselaar, Hj; Danese, S | |
| COMPARATIVE ACCURACY OF US VERSUS MRI AND COLONOSCOPY IN ASSESSING DISEASE ACTIVITY AND COMPLICATIONS AND INFLUENCING THE DECISION-MAKING PROCESS IN CROHN'S DISEASE | 1-gen-2017 | Allocca, M; Fiorino, G; Bonifacio, C; Furfaro, F; Radice, S; Gilardi, D; Peyrin-Biroulet, L; Danese, S | |
| Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds | 1-gen-2010 | Di Pucchio, T; Danese, S; De Cristofaro, R; Rutella, S | |
| Comparison between intravenous iron gluconate alone and intravenous iron gluconate plus levofolinic acid for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease | 1-gen-2006 | Papa, A; Danese, S; Guglielmo, S; Roberto, I; Covino, M; Grillo, A; Urgesi, R; Semeraro, S; Bonizzi, M; Tagliaferri, F; Guidi, L; de Vitis, I; Fedeli, G; Gasbarrini, G; Gasbarrini, A | |
| Helicobacter pylori infection in rheumatoid arthritis - Reply | 1-gen-2001 | Danese, S; Gasbarrini, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1